The inhibition of several components of terminal complement pathway results in C3 binding to PNH red blood cells
American Journal of Hematology · 2024-03 · 99 (3) · 505-507
DOI: 10.1002/ajh.27215 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Hematology, online erschienen am 24.01.2024. Verfasst von Michela Sica und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Genetics and Gene Transfer, Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Flore…. Hauptthemen laut MEDLINE: Hemoglobinuria, Paroxysmal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: Istituto Toscano Tumori.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Cancer Genetics and Gene Transfer, Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Florence, Italy.
ORCID-Profile: Michela Sica, Rosario Notaro
Förderung
- Istituto Toscano Tumori
Zitieren
APA
Sica, M., & Notaro, R. (2024). The inhibition of several components of terminal complement pathway results in C3 binding to PNH red blood cells. American Journal of Hematology, 99(3), 505-507. https://doi.org/10.1002/ajh.27215
Vancouver
Sica M, Notaro R. The inhibition of several components of terminal complement pathway results in C3 binding to PNH red blood cells. American Journal of Hematology. 2024;99(3):505-507. doi:10.1002/ajh.27215
BibTeX
@article{Sica2024,
author = {Sica, Michela and Notaro, Rosario},
title = {The inhibition of several components of terminal complement pathway results in C3 binding to PNH red blood cells},
journal = {American Journal of Hematology},
year = {2024},
volume = {99},
number = {3},
pages = {505--507},
doi = {10.1002/ajh.27215}
}
EUVIMED